Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages

  Yu, James B ^a   Soulos, Pamela R ^a   Sharma, Richa ^b   Makarov, Danil V ^a,c   Decker, Roy H ^a   Smith, Benjamin D ^d   Desai, Rani A ^e,f   Cramer, Laura D ^a   Gross, Cary P ^a,f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e YALE UNIVERSITY   (United States)

^f Robert Wood Johnson Clinical Scholars Program at Yale   (United States)

Author keywords

Comparative effectiveness; End Results Medicare; Epidemiology; Head and neck cancer; Intensity modulated radiation therapy; Surveillance

Indexed keywords

COHORT STUDIES; COMPARATIVE EFFECTIVENESS; CONVENTIONAL RADIATION THERAPY; COX MODEL; END RESULTS-MEDICARE; HEAD AND NECK; HEAD-AND-NECK CANCER; INTENSITY MODULATED RADIATION THERAPY; NATIONAL CANCER INSTITUTE; OVERALL SURVIVAL; PATTERNS OF CARE;

DISEASES; EPIDEMIOLOGY; HEALTH INSURANCE; PATIENT MONITORING; RADIOTHERAPY; SPACE SURVEILLANCE;

PHYSICAL THERAPY;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICARE; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEDICARE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84862810198     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.067     Document Type: Article

References (20)

1. J.A. Langendijk, P. Doornaert, and I.M. Verdonck-de Leeuw Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
2. R.B. Kuppersmith, S.C. Greco, and B.S. Teh Intensity-modulated radiotherapy: First results with this new technology on neoplasms of the head and neck Ear Nose Throat J 78 238 1999 241 246 248 passim
3. L.K. Mell, A.K. Mehrotra, and A.J. Mundt Intensity-modulated radiation therapy use in the U.S., 2004 Cancer 104 2005 1296 1303
4. S. Tribius, and C. Bergelt Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: Is there a worthwhile quality of life gain? Cancer Treat Rev 37 2011 511 519
5. C.M. Nutting, J.P. Morden, and K.J. Harrington Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
6. W.M. Mendenhall, R.J. Amdur, and J.R. Palta Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls J Clin Oncol 24 2006 2618 2623
7. S. Seung, J. Bae, and M. Solhjem Intensity-modulated radiotherapy for head-and-neck cancer in the community setting Int J Radiat Oncol Biol Phys 72 2008 1075 1081
8. G.J. Kubicek, B.F. Kimler, and F. Wang Chemotherapy in head and neck cancer: Clinical predictors of tolerance and outcomes Am J Clin Oncol 34 2011 380 384
9. J.B. Yu, C.P. Gross, and L.D. Wilson NCI SEER public-use data: Applications and limitations in oncology research Oncology (Williston Park) 23 2009 288 295
10. J.L. Warren, C.N. Klabunde, and D. Schrag Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3 IV-18
11. B.A. Virnig, J.L. Warren, and G.S. Cooper Studying radiation therapy using SEER-Medicare-linked data Med Care 40 2002 IV-49 IV-54
12. J.L. Warren, L.C. Harlan, and A. Fahey Utility of the SEER-Medicare data to identify chemotherapy use Med Care 40 2002 IV-55 IV-61
13. S.J. Feigenberg, M. Lango, and N. Nicolaou Intensity-modulated radiotherapy for early larynx cancer: Is there a role? Int J Radiat Oncol Biol Phys 68 2007 2 3
14. M.D. Fesinmeyer, V. Mehta, and L. Tock Completion of radiotherapy for local and regional head and neck cancer in Medicare Arch Otolaryngol Head Neck Surg 135 2009 860 867
15. A. Elixhauser, C. Steiner, and D.R. Harris Comorbidity measures for use with administrative data Med Care 36 1998 8 27
16. S.H. Giordano, Y.F. Kuo, and Z. Duan Limits of observational data in determining outcomes from cancer therapy Cancer 112 2008 2456 2466
17. E. Orlandi, M. Palazzi, and E. Pignoli Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review Crit Rev Oncol Hematol 73 2010 111 125
18. A.M. Traynor, G.M. Richards, and G.K. Hartig Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience Head Neck 32 2010 599 606
19. B.C. Reid, A.J. Alberg, and A.C. Klassen Comorbidity and survival of elderly head and neck carcinoma patients Cancer 92 2001 2109 2116
20. B.A. Guadagnolo, C.C. Liu, and J.N. Cormier Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: Socioeconomic disparity and geographic variation in a large population-based cohort Cancer 116 2010 3505 3512